Spironolactone is associated with reduced risk of new-onset atrial fibrillation in patients receiving renal replacement therapy

Yi Wei Chung, Yao Hsu Yang, Cho Kai Wu, Chih Chieh Yu, Jyh Ming Jimmy Juang, Yi Chih Wang, Chia Ti Tsai, Lian Yu Lin, Ling Ping Lai, Juey Jen Hwang, Fu Tien Chiang, Pau Chung Chen, Jiunn Lee Lin

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Spironolactone is associated with reduced risk of new-onset atrial fibrillation in patients receiving renal replacement therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences